| TIMER2. 0 for analysis of tumor-infiltrating immune cells T Li, J Fu, Z Zeng, D Cohen, J Li, Q Chen, B Li, XS Liu Nucleic acids research 48 (W1), W509-W514, 2020 | 3745 | 2020 |
| Transfer learning enables predictions in network biology CV Theodoris, L Xiao, A Chopra, MD Chaffin, ZR Al Sayed, MC Hill, ... Nature 618 (7965), 616-624, 2023 | 422 | 2023 |
| Natural language processing for EHR-based pharmacovigilance: a structured review Y Luo, WK Thompson, TM Herr, Z Zeng, MA Berendsen, ... Drug safety 40, 1075-1089, 2017 | 197 | 2017 |
| Natural language processing for EHR-based computational phenotyping Z Zeng, Y Deng, X Li, T Naumann, Y Luo IEEE/ACM transactions on computational biology and bioinformatics 16 (1 …, 2018 | 195 | 2018 |
| Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade SS Gu, W Zhang, X Wang, P Jiang, N Traugh, Z Li, C Meyer, B Stewig, ... Cancer discovery 11 (6), 1524-1541, 2021 | 160 | 2021 |
| Statistical and machine learning methods for spatially resolved transcriptomics data analysis Z Zeng, Y Li, Y Li, Y Luo Genome biology 23 (1), 83, 2022 | 141 | 2022 |
| In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target X Wang, C Tokheim, SS Gu, B Wang, Q Tang, Y Li, N Traugh, Z Zeng, ... Cell 184 (21), 5357-5374. e22, 2021 | 131 | 2021 |
| Early prediction of acute kidney injury following ICU admission using a multivariate panel of physiological measurements LP Zimmerman, PA Reyfman, ADR Smith, Z Zeng, A Kho, ... BMC medical informatics and decision making 19, 1-12, 2019 | 103 | 2019 |
| Using natural language processing and machine learning to identify breast cancer local recurrence Z Zeng, S Espino, A Roy, X Li, SA Khan, SE Clare, X Jiang, R Neapolitan, ... BMC bioinformatics 19, 65-74, 2018 | 86 | 2018 |
| Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α L Wu, Y Jin, X Zhao, K Tang, Y Zhao, L Tong, X Yu, K Xiong, C Luo, J Zhu, ... Cell Metabolism 35 (9), 1580-1596. e9, 2023 | 80 | 2023 |
| TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response Z Zeng, CJ Wong, L Yang, N Ouardaoui, D Li, W Zhang, S Gu, Y Zhang, ... Nucleic acids research 50 (D1), D1391-D1397, 2022 | 79 | 2022 |
| CARM1 inhibition enables immunotherapy of resistant tumors by dual action on tumor cells and T cells S Kumar, Z Zeng, A Bagati, RE Tay, LA Sanz, SR Hartono, Y Ito, ... Cancer discovery 11 (8), 2050-2071, 2021 | 66 | 2021 |
| Discovering causal interactions using Bayesian network scoring and information gain Z Zeng, X Jiang, R Neapolitan BMC bioinformatics 17, 1-14, 2016 | 65* | 2016 |
| Identifying breast cancer distant recurrences from electronic health records using machine learning Z Zeng, L Yao, A Roy, X Li, S Espino, SE Clare, SA Khan, Y Luo Journal of healthcare informatics research 3, 283-299, 2019 | 50 | 2019 |
| A two-level iteration approach for modeling and analysis of rapid response process with multiple deteriorating patients Z Zeng, Z Fan, X Xie, CH Swartz, P DePriest, J Li Flexible Services and Manufacturing Journal 32, 35-71, 2020 | 41* | 2020 |
| Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer G Oliveira, AM Egloff, AB Afeyan, JO Wolff, Z Zeng, RD Chernock, L Zhou, ... Science immunology 8 (87), eadf4968, 2023 | 40 | 2023 |
| Deep generative classifiers for thoracic disease diagnosis with chest x-ray images C Mao, L Yao, Y Pan, Y Luo, Z Zeng 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2018 | 39 | 2018 |
| Deep learning for cancer type classification and driver gene identification Z Zeng, C Mao, A Vo, L Xiaoyu, JO Nugent, SA Khan, SE Clare, Y Luo BMC bioinformatics, 612762, 2021 | 37* | 2021 |
| Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders L Zhou, Z Zeng, AM Egloff, F Zhang, F Guo, KM Campbell, P Du, J Fu, ... Journal for immunotherapy of cancer 10 (1), 2022 | 34 | 2022 |
| Cancer classification and pathway discovery using non-negative matrix factorization Z Zeng, AH Vo, C Mao, SE Clare, SA Khan, Y Luo Journal of biomedical informatics 96, 103247, 2019 | 33 | 2019 |
Xiaole Shirley LiuCEO, GV20 TherapeuticsVerified email at ds.dfci.harvard.edu